6-Bromoimidazo[1,2-a]pyridine-2-carbaldehyde, 95.0%, 1g

Ethyl 2-(2,4-difluorophenyl)-2,2-difluoroacetate, 95.0%, 250mg

Ethyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate, 95.0%, 250mg

Methyl 6-O-(N-heptylcarbamoyl)-a-D-glucopyranoside, 99.0%, 1g

1-tetradecyl-1,4-diazepane, 95.0%, 5g

Ethyl 4-phenylbut-2-enoate, 97.0%, 250mg

Columna capilar GC ROTI®Cap-5, 15 m, 0,32 mm, 1,00 µm, 1 Pieza(s)

2-Chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 10g

2-(phenylamino)-2-(pyridin-3-yl)acetonitrile, 95.0%, 2g

5-Bromobenzo[c][1,2,5]oxadiazole, 95.0%, 5g

N-acetilglicina, mínimo 99 %, para bioquímica, 25 g, envase de plástico.

6-Chloro-2-(chloromethyl)-3-fluoropyridine, 95%, 1g

1-(2-Methoxyethyl)-4-nitro-1h-pyrazole, 97%, 5g